Triiodothyronine and free thyroxine levels are differentially associated with metabolic profile and adiposity-related cardiovascular risk markers in euthyroid middle-aged subjects

Thyroid

Volumn 24, Issue 2, 2014, Pages 223-231

  Roef, Greet L ^a   Rietzschel, Ernst R ^a   Van Daele, Caroline M ^a   Taes, Youri E ^a   De Buyzere, Marc L ^a   Gillebert, Thierry C ^a   Kaufman, Jean Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RISK FACTORS; THYROTROPIN; THYROXINE; TRIGLYCERIDES; TRIIODOTHYRONINE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84894192873     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2013.0314     Document Type: Article

References (52)

1. Hoogwerf BJ, Nuttall FQ 1984 Long-term weight regulation in treated hyperthyroid and hypothyroid subjects. Am J Med 76:963-970.
2. De Pergola G, Ciampolillo A, Paolotti S, Trerotoli P, Giorgino R 2007 Free triiodothyronine and thyroid stimulating hormone are directly associated with waist circumference, independently of insulin resistance, metabolic parameters and blood pressure in overweight and obese women. Clin Endocrinol (Oxf) 67:265-269.
3. Diez JJ, Iglesias P 2011 Relationship between thyrotropin and body mass index in euthyroid subjects. Exp Clin Endocrinol Diabetes 119:144-150.
4. Reinehr T, Isa A, De Sousa G, Dieffenbach R, Andler W 2008 Thyroid hormones and their relation to weight status. Horm Res 70:51-57.
5. Reinehr T 2010 Obesity and thyroid function. Mol Cell Endocrinol 316:165-171.
6. Fox CS, Pencina MJ, D'Agostino RB, Murabito JM, Seely EW, Pearce EN, Vasan RS 2008 Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med 168:587-592.
7. Kim BJ, Kim TY, Koh JM, Kim HK, Park JY, Lee KU, Shong YK, Kim WB 2009 Relationship between serum free T4 (FT4) levels and metabolic syndrome (MS) and its components in healthy euthyroid subjects. Clin Endocrinol (Oxf) 70:152-160.
8. Kitahara CM, Platz EA, Ladenson PW, Mondul AM, Menke A, Berrington De González A 2012 Body fatness and markers of thyroid function among U. S. men and women. PLoS One 7:e34979.
9. Ortega E, Koska J, Pannacciulli N, Bunt JC, Krakoff J 2008 Free triiodothyronine plasma concentrations are positively associated with insulin secretion in euthyroid individuals. Eur J Endocrinol 158:217-221.
10. Roef G, Lapauw B, Goemaere S, Zmierczak HG, Toye K, Kaufman JM, Taes Y 2012 Body composition and metabolic parameters are associated with variation in thyroid hormone levels among euthyroid young men. Eur J Endocrinol 167:719-726.
11. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH 2007 Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab 92:491-496.
12. Garduno-Garcia JJ, Alvirde-Garcia U, Lopez-Carrasco G, Padilla Mendoza ME, Mehta R, Arellano-Campos O, Choza R, Sauque L, Garay-Sevilla ME, Malacara JM, Gomez-Perez FJ, Aguilar-Salinas CA 2010 TSH and free thyroxine concentrations are associated with differing metabolic markers in euthyroid subjects. Eur J Endocrinol 163:273-278.
13. Asvold BO, Bjoro T, Nilsen TI, Vatten LJ 2007 Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a populationbased study. J Clin Endocrinol Metab 92:841-845.
14. Boekholdt SM, Titan SM, Wiersinga WM, Chatterjee K, Basart DC, Luben R, Wareham NJ, Khaw KT 2010 Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf) 72:404-410.
15. Gumieniak O, Perlstein TS, Hopkins PN, Brown NJ, Murphey LJ, Jeunemaitre X, Hollenberg NK, Williams GH 2004 Thyroid function and blood pressure homeostasis in euthyroid subjects. J Clin Endocrinol Metab 89:3455-3461.
16. Ittermann T, Tiller D, Meisinger C, Agger C, Nauck M, Rettig R, Hofman A, Franco O, Joergensen T, Linneberg A, Witteman J, Greiser H, Werdan K, Doring A, Kluttig A, Stricker B, Volzke H 2013 High serumTSH levels are associated with current but not with incident hypertension. Thyroid 23:955-963.
17. Liu D, Jiang F, Shan Z, Wang B, Wang J, Lai Y, Chen Y, Li M, Liu H, Li C, Xue H, Li N, Yu J, Shi L, Bai X, Hou X, Zhu L, Lu L, Wang S, Xing Q, Teng W 2010 A cross-sectional survey of relationship between serum TSH level and blood pressure. J Hum Hypertens 24:134-138.
18. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T 2007 The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol 156:181-186.
19. Lu L, Wang B, Shan Z, Jiang F, Teng X, Chen Y, Lai Y, Wang J, Xue H, Wang S, Li C, Liu H, Li N, Yu J, Shi L, Hou X, Xing Q, Bai X, Teng W 2011 The correlation between thyrotropin and dyslipidemia in a population-based study. J Korean Med Sci 26:243-249.
20. Wang F, Tan Y, Wang C, Zhang X, Zhao Y, Song X, Zhang B, Guan Q, Xu J, Zhang J, Zhang D, Lin H, Yu C, Zhao J 2012 Thyroid-stimulating hormone levels within the reference range are associated with serum lipid profiles independent of thyroid hormones. J Clin Endocrinol Metab 97:2724-2731.
21. Bassols J, Prats-Puig A, Soriano-Rodriguez P, Garcia-Gonzalez MM, Reid J, Martinez-Pascual M, Mateos-Comeron F, De Zegher F, Ibanez L, Lopez-Bermejo A 2011 Lower free thyroxin associates with a less favorable metabolic phenotype in healthy pregnant women. J Clin Endocrinol Metab 96:3717-3723.
22. Biondi B 2012 How could we improve the increased cardiovascular mortality in patients with overt and subclinical hyperthyroidism? Eur J Endocrinol 167:295-299.
23. Cappola AR, Fried LP, Arnold AM, Danese MD, Kuller LH, Burke GL, Tracy RP, Ladenson PW 2006 Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295:1033-1041.
24. Duggal J, Singh S, Barsano CP, Arora R 2007 Cardiovascular risk with subclinical hyperthyroidism and hypothyroidism: pathophysiology and management. J Cardiometab Syndr 2:198-206.
25. Gencer B, Collet TH, Virgini V, Bauer DC, Gussekloo J, Cappola AR, Nanchen D, Den Elzen WP, Balmer P, Luben RN, Iacoviello M, Triggiani V, Cornuz J, Newman AB, Khaw KT, Jukema JW, Westendorp RG, Vittinghoff E, Aujesky D, Rodondi N 2012 Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation 126:1040-1049.
26. Gencer B, Collet TH, Virgini V, Auer R, Rodondi N 2013 Subclinical thyroid dysfunction and cardiovascular outcomes among prospective cohort studies. Endocr Metab Immune Disord Drug Targets 13:4-12.
27. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC 2000 Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med 132:270-278.
28. Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema P, Michelangeli V 2005 Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med 165:2467-2472.
29. Westerink J, Van Der GY, Faber DR, Spiering W, Visseren FL 2012 Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases. Eur J Cardiovasc Prev Rehabil 19:864-873.
30. Dullaart RP, De Vries R, Roozendaal C, Kobold AC, Sluiter WJ 2007 Carotid artery intima media thickness is inversely related to serum free thyroxine in euthyroid subjects. Clin Endocrinol (Oxf) 67:668-673.
31. Lambrinoudaki I, Armeni E, Rizos D, Georgiopoulos G, Kazani M, Alexandrou A, Deligeoroglou E, Livada A, Psychas C, Creatsa M, Bouboulis G, Alevizaki M, Stamatelopoulos K 2012 High normal thyroid-stimulating hormone is associated with arterial stiffness in healthy postmenopausal women. J Hypertens 30:592-599.
32. Takamura N, Akilzhanova A, Hayashida N, Kadota K, Yamasaki H, Usa T, Nakazato M, Maeda T, Ozono Y, Aoyagi K 2009 Thyroid function is associated with carotid intimamedia thickness in euthyroid subjects. Atherosclerosis 204:e77-e81.
33. Peters A, Ehlers M, Blank B, Exler D, Falk C, Kohlmann T, Fruehwald-Schultes B, Wellhoener P, Kerner W, Fehm HL 2000 Excess triiodothyronine as a risk factor of coronary events. Arch Intern Med 160:1993-1999.
34. Kim ES, Shin JA, Shin JY, Lim DJ, Moon SD, Son HY, Han JH 2012 Association between low serum free thyroxine concentrations and coronary artery calcification in healthy euthyroid subjects. Thyroid 22:870-876.
35. Rietzschel ER, De Buyzere ML, Bekaert S, Segers P, De Bacquer D, Cooman L, Van Damme P, Cassiman P, Langlois M, Van Oostveldt P, Verdonck P, De Backer G, Gillebert TC 2007 Rationale, design, methods and baseline characteristics of the Asklepios Study. Eur J Cardiovasc Prev Rehabil 14:179-191.
36. Rietzschel ER, Langlois M, De Buyzere ML, Segers P, De Bacquer D, Bekaert S, Cooman L, Van Oostveldt P, Verdonck P, De Backer GG, Gillebert TC 2008 Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations. Hypertension 52:535-541.
37. Roef GL, Taes YE, Kaufman JM, Van Daele C, De Buyzere ML, Gillebert TC, Rietzschel ER 2013 Thyroid hormone levels within reference range are associated with heart rate, cardiac structure and function in middle-aged men and women. Thyroid 23:947-954.
38. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr 2009 Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640-1645.
39. Segers P, Rietzschel ER, De Buyzere ML, Vermeersch SJ, De Bacquer D, Van Bortel LM, De Backer G, Gillebert TC, Verdonck PR 2007 Noninvasive (input) impedance, pulse wave velocity, and wave reflection in healthy middle-aged men and women. Hypertension 49:1248-1255.
40. Vermeersch SJ, Rietzschel ER, De Buyzere ML, De Bacquer D, De Backer G, Van Bortel LM, Gillebert TC, Verdonck PR, Segers P 2008 Age and gender related patterns in carotidfemoral PWV and carotid and femoral stiffness in a large healthy, middle-aged population. J Hypertens 26:1411-1419.
41. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC 1974 Enzymatic determination of total serum cholesterol. Clin Chem 20:470-475.
42. Alevizaki M, Saltiki K, Voidonikola P, Mantzou E, Papamichael C, Stamatelopoulos K 2009 Free thyroxine is an independent predictor of subcutaneous fat in euthyroid individuals. Eur J Endocrinol 161:459-465.
43. Shon HS, Jung ED, Kim SH, Lee JH 2008 Free T4 is negatively correlated with body mass index in euthyroid women. Korean J Intern Med 23:53-57.
44. Manji N, Boelaert K, Sheppard MC, Holder RL, Gough SC, Franklyn JA 2006 Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol (Oxf) 64:125-128.
45. Macek JZ, Pavelka S, Flachs P, Hensler M, Kus V, Kopecky J 2010 Modulation of type I iodothyronine 5'-deiodinase activity in white adipose tissue by nutrition: possible involvement of leptin. Physiol Res 59:561-569.
46. Ortega FJ, Jilkova ZM, Moreno-Navarrete JM, Pavelka S, Rodriguez-Hermosa JI, Kopeck YJ, Fernandez-Real JM 2012 Type I iodothyronine 5'-deiodinase mRNA and activity is increased in adipose tissue of obese subjects. Int J Obes (Lond) 36:320-324.
47. Bianco AC, Kim BW 2006 Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116:2571-2579.
48. Torriani M, Fitch K, Stavrou E, Bredella MA, Lim R, Sass CA, Cypess AM, Grinspoon S 2012 Deiodinase 2 expression is increased in dorsocervical fat of patients with HIV-associated lipohypertrophy syndrome. J Clin Endocrinol Metab 97:E602-E607.
49. Duntas LH, Wartofsky L 2007 Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid 17:1075-1084.
50. Duntas LH, Brenta G 2012 The effect of thyroid disorders on lipid levels and metabolism. Med Clin North Am 96:269-281.
51. Fabbrini E, Magkos F, Patterson BW, Mittendorfer B, Klein S 2012 Subclinical hypothyroidism and hyperthyroidism have opposite effects on hepatic very-low-density lipoprotein-triglyceride kinetics. J Clin Endocrinol Metab 97:E414-E418.
52. Pearce EN 2012 Update in lipid alterations in subclinical hypothyroidism. J Clin Endocrinol Metab 97:326-333.